1.04
price down icon1.89%   -0.02
 
loading
Precedente Chiudi:
$1.06
Aprire:
$1.06
Volume 24 ore:
76,831
Relative Volume:
0.45
Capitalizzazione di mercato:
$23.75M
Reddito:
$950.10K
Utile/perdita netta:
$-16.69M
Rapporto P/E:
-1.0833
EPS:
-0.96
Flusso di cassa netto:
$-15.16M
1 W Prestazione:
+6.45%
1M Prestazione:
-18.11%
6M Prestazione:
-18.75%
1 anno Prestazione:
+0.97%
Intervallo 1D:
Value
$1.03
$1.07
Intervallo di 1 settimana:
Value
$0.96
$1.20
Portata 52W:
Value
$0.734
$2.40

Femasys Inc Stock (FEMY) Company Profile

Name
Nome
Femasys Inc
Name
Telefono
770-500-3910
Name
Indirizzo
3950 JOHNS CREEK COURT, SUWANEE
Name
Dipendente
34
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
FEMY's Discussions on Twitter

Confronta FEMY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Instruments & Supplies icon
FEMY
Femasys Inc
1.04 23.75M 950.10K -16.69M -15.16M -0.96
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
538.55 192.83B 7.87B 2.24B 586.00M 4.25
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
221.98 64.77B 20.18B 1.73B 3.07B 5.51
Medical Instruments & Supplies icon
ALC
Alcon Inc
88.23 43.75B 9.76B 1.16B 665.00M 0.72
Medical Instruments & Supplies icon
RMD
Resmed Inc
249.33 36.84B 4.81B 1.11B 1.35B 6.16
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
323.32 23.33B 2.88B 499.60M 321.60M 7.41

Femasys Inc Borsa (FEMY) Ultime notizie

pulisher
Nov 27, 2024

The Latest Analyst Ratings For Femasys - Benzinga

Nov 27, 2024
pulisher
Nov 26, 2024

Femasys Announces Peer-Reviewed Publication of Positive - GlobeNewswire

Nov 26, 2024
pulisher
Nov 26, 2024

Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment - Yahoo Canada Finance

Nov 26, 2024
pulisher
Nov 20, 2024

Femasys price target lowered to $8 from $10 at Chardan - MSN

Nov 20, 2024
pulisher
Nov 15, 2024

Femasys Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 15, 2024
pulisher
Nov 14, 2024

Femasys Inc. (FEMY) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 12, 2024

Femasys Inc. (FEMY) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 12, 2024
pulisher
Nov 12, 2024

Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides - The Bakersfield Californian

Nov 12, 2024
pulisher
Nov 12, 2024

Femasys Sales Surge 127% as Boston IVF Partnership, FDA Clearance Fuel Growth | FEMY Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 07, 2024

Femasys to Exhibit at the Annual AAGL 2024 Global Conference - GlobeNewswire

Nov 07, 2024
pulisher
Nov 05, 2024

FEMYFemasys Inc. Latest Stock News & Market Updates - StockTitan

Nov 05, 2024
pulisher
Nov 05, 2024

Femasys Partners with Boston IVF to Expand Access to Novel Fertility Treatment - Femtech Insider

Nov 05, 2024
pulisher
Nov 01, 2024

Femasys secures new patent for FemBloc birth control By Investing.com - Investing.com South Africa

Nov 01, 2024
pulisher
Nov 01, 2024

Femasys issued U.S. patent covering FemBloc device - MSN

Nov 01, 2024
pulisher
Nov 01, 2024

Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control - GlobeNewswire

Nov 01, 2024
pulisher
Nov 01, 2024

Femasys secures new patent for FemBloc birth control - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

The 10 Best Booths from ASRM 2022 - Exhibitor Online

Nov 01, 2024
pulisher
Oct 31, 2024

Femasys (NASDAQ:FEMY) Has Debt But No Earnings; Should You Worry? - Simply Wall St

Oct 31, 2024
pulisher
Oct 31, 2024

Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed - GlobeNewswire

Oct 31, 2024
pulisher
Oct 29, 2024

Femasys Advances in Women’s Health Innovation - TipRanks

Oct 29, 2024
pulisher
Oct 10, 2024

Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program - GlobeNewswire

Oct 10, 2024
pulisher
Oct 08, 2024

Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - The Manila Times

Oct 08, 2024
pulisher
Oct 02, 2024

Femasys Receives Second Order from Spain Partners After - GlobeNewswire

Oct 02, 2024
pulisher
Oct 02, 2024

Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments - StockTitan

Oct 02, 2024
pulisher
Sep 18, 2024

Femasys announes infertility clinic customers from coast to coast - TipRanks

Sep 18, 2024
pulisher
Sep 18, 2024

Femasys Announces Infertility Clinic Customers from Coast to Coast - GlobeNewswire

Sep 18, 2024
pulisher
Sep 12, 2024

H.C. Wainwright maintains Buy rating on Femasys on secureing strategic Spain distribution - Investing.com India

Sep 12, 2024
pulisher
Sep 12, 2024

Femasys Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga

Sep 12, 2024
pulisher
Sep 11, 2024

Femasys secures distribution partnerships for commercialization of FemaSeed - TipRanks

Sep 11, 2024
pulisher
Sep 11, 2024

Femasys Secures Strategic Distribution Partnerships for - GlobeNewswire

Sep 11, 2024
pulisher
Sep 11, 2024

Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market - StockTitan

Sep 11, 2024
pulisher
Sep 10, 2024

Femasys Stock Rises After FDA Clearance for FemChec Diagnostic Device - Yahoo Finance

Sep 10, 2024
pulisher
Sep 09, 2024

Items Tagged with 'Femchec' - BioWorld Online

Sep 09, 2024
pulisher
Sep 09, 2024

Femasys gains FDA clearance for new diagnostic tool FemChec - Investing.com India

Sep 09, 2024
pulisher
Sep 09, 2024

Femasys Femchec receives FDA clearance - BioWorld Online

Sep 09, 2024
pulisher
Sep 09, 2024

Femasys gains FDA clearance for new diagnostic tool FemChec By Investing.com - Investing.com UK

Sep 09, 2024
pulisher
Sep 09, 2024

Femasys Inc. Receives U.S. FDA Clearance to Market - GlobeNewswire

Sep 09, 2024
pulisher
Sep 09, 2024

Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check - StockTitan

Sep 09, 2024
pulisher
Sep 05, 2024

Femasys to Exhibit at The Canadian Fertility and Andrology Society’s 70th Annual Meeting - GlobeNewswire

Sep 05, 2024
pulisher
Sep 04, 2024

Femasys Shares Rise on CE Mark & Canada Approval for FemVue MINI - MSN

Sep 04, 2024
pulisher
Sep 03, 2024

Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire

Sep 03, 2024

Femasys Inc Azioni (FEMY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.04
price up icon 0.14%
medical_instruments_supplies BAX
$33.31
price up icon 1.34%
$229.66
price up icon 0.76%
$79.44
price up icon 0.56%
medical_instruments_supplies COO
$103.43
price up icon 0.77%
medical_instruments_supplies WST
$323.32
price up icon 1.24%
Capitalizzazione:     |  Volume (24 ore):